DETAILS, FICTION AND MBL77

mutations given The point that, as spelled out beneath, CLL therapy relies to the presence or absence of such mutations. The existing consensus is usually that, apart from clonal mutations, subclonal mutations which has a variant allelic frequency starting from 5 to 10% (and therefore under the edge of detection by traditional molecular strategies)